InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Jarrett Jennifer, Chief Operating Officer. Director active across 6 companies, notably Arcus Biosciences, Inc.. Cumulatively, 43 disclosures have been published. Breakdown: 0 buy · 22 sells. Total volume traded: €5.4m. Activity tracked since 4 June 2021. The latest transaction was filed on 30 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Jarrett Jennifer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations43 total
500,000 shares0Common StockSEC:0001193125-26-138275:0
24,000 shares0Common StockSEC:0001193125-26-041412:0
31,000 shares0Common StockSEC:0001671311-26-000002:0
11,225 shares@ US$21.88433.1% of flowCommon StockSEC:0001671311-25-000009:0
50,291 shares@ US$1.22760.8% of flowCommon StockSEC:0001671311-25-000005:0
12,500 shares@ US$1.22760.0004% mcap0.6% of flowCommon StockSEC:0001671311-25-000003:0
25,000 shares0Common StockSEC:0000950170-25-016357:0
50,000 shares0Common StockSEC:0001724521-25-000018:0
27,501 shares@ US$16.085.8% of flowCommon StockSEC:0001724521-24-000184:0
12,670 shares@ US$17.952.8% of flowCommon StockSEC:0001724521-24-000150:0
12,670 shares@ US$16.972.7% of flowCommon StockSEC:0001724521-24-000127:0
11,551 shares@ US$17.552.6% of flowCommon StockSEC:0001724521-24-000071:0
12,153 shares@ US$17.842.7% of flowCommon StockSEC:0001724521-24-000068:0
24,555 shares@ US$20.076.2% of flowCommon StockSEC:0001724521-24-000063:0
17,000 shares0Common StockSEC:0001562180-24-001219:0
40,000 shares0Common StockSEC:0001724521-24-000025:0
21,521 shares@ US$17.764.7% of flowCommon StockSEC:0001724521-23-000076:0
11,250 shares@ US$17.742.5% of flowCommon StockSEC:0001724521-23-000066:0
21,369 shares@ US$19.998.0% of flowCommon StockSEC:0001724521-23-000011:0
12,506 shares@ US$20.404.8% of flowCommon StockSEC:0001724521-23-000006:0
45,000 shares@ US$20.2511.3% of flowCommon StockSEC:0001209191-23-043821:0
12,437 shares@ US$19.123.0% of flowCommon StockSEC:0001209191-23-039718:0
12,563 shares@ US$19.353.0% of flowCommon StockSEC:0001209191-23-038157:0
8,729 shares@ US$16.811.9% of flowCommon StockSEC:0001209191-23-020037:0
16,000 shares0Common StockSEC:0001562180-23-000942:0
25 of 43 declarations
About Jarrett Jennifer
Jarrett Jennifer is Directeur des Opérations and has filed 43 disclosures in total. In the recent sampled filings, covering the period from 2021-06-07 to 2026-04-01, sales amount to EUR 5,793,675 and the modal transaction nature is Cession. The companies mentioned are Arcus Biosciences, Inc., Syndax Pharmaceuticals Inc, Arena Pharmaceuticals INC, Damora Therapeutics, Inc., and Surrozen, Inc./DE.
